Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002013
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Safety Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDSARC Patients
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
A Safety Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDSARC Patients
Status:
COMPLETED
Status Verified Date:
1990-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate safety pharmacokinetics immunologic parameters and neurocognitive data for three dosages of AS-101 in combination with zidovudine AZT in patients with AIDS or AIDS related complex ARC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 753A-109-US | None | None | None |